Track topics on Twitter Track topics that are important to you
Major commercial insurer renews contract of NaviNet Open and adds NantHealth’s Document Exchange solution to their rolodex
NantHealth, Inc.(NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that Blue Cross and Blue Shield of Nebraska (BCBSNE),a NantHealth client since 2010, and the largest commercial insurer in the state of Nebraska, has signed a three-year contract extension for NaviNet Open.
Along with extending their contract, BCBSNE adds NantHealth’s NaviNet Open Document Exchange solution to its existing NantHealth solution line which currently includes NaviNet Open application subscriptions such as Eligibility & Benefits, Claim Status, and Single Sign-On (SSO) enablement.
“As adoption of value-based care programs continues to grow among payers and providers, there is a critical need to establish more collaborative partnerships,” said Dr. Patrick Soon-Shiong, founder and CEO of NantHealth. “As a result, we must find ways to enrich the collaboration between payers and providers. This is where technology will step up to play a big part in that role. We’re looking forward to our continued partnership with BCBSNE and are excited to onboard them with the NaviNet Open Document Exchange solution.”
BCBSNE was an original Beta partner for the NaviNet Open platform, and as part of the renewal, the company has become the latest NantHealth payer client to purchase the NaviNet Open Document Exchange solution, with the plan to use it to facilitate e-delivery of fee schedules.
NaviNet Open Document Exchange enables a HIPAA-safe exchange of clinical information among multiple medical management, informatics, and care delivery teams with the goal of empowering health plans to better communicate and engage with their provider networks in real-time. The flexible solution allows providers to easily access, review, modify, and return documents in pursuit of population health and fee-for-value program initiatives. By meshing clinical intelligence with administrative workflows, NaviNet Open Document Exchange enables effective payer-provider collaboration to improve patient outcomes and boost efficiency.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding the capabilities and anticipated utility of our GPS Cancer, including predicting patient response and resistance to therapeutics, enabling diagnoses by physicians and accelerating efforts to bring novel combinations of therapeutic agents to cancer patients. Forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results. Factors that may cause future results to differ materially from management’s current expectations include, among other things, that GPS Cancer may not perform as anticipated, that sufficient physicians may not adopt GPS Cancer to assist their diagnoses or that healthcare payers may not provide reimbursement for GPS Cancer as expected. Our business is subject to numerous additional risks and uncertainties, including, among others, risks relating to market acceptance of our products; our ability to successfully launch new products and applications; competition; our sales, marketing and distribution capabilities; our planned sales, marketing, and research and development activities; unanticipated increases in costs or expenses; and risks associated with international operations. Information on these and additional risks, uncertainties, and other information affecting our business and operating results can be found in our existing and future filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. We disclaim any obligation to update these forward-looking statements except as may be required by law.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth's unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine. For nearly a decade, NantHealth has developed an adaptive learning system, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time. For more information please visit www.nanthealth.com and follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.
About Blue Cross Blue Shield Nebraska
Blue Cross and Blue Shield of Nebraska is a community-based, member-owned health insurance company serving Nebraskans for more than 75 years. BCBSNE is committed to providing stability and security to Nebraska families and is leading the way in supporting patient-focused care. We’re the state’s largest health insurance company, and the only one headquartered in Nebraska. Blue Cross and Blue Shield of Nebraska is an independent licensee of the Blue Cross and Blue Shield Association.
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...